Recruiting Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia NCT04881240 Conditions Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, +11 more Locations St. Jude Children's Research Hospital — Memphis, Tennessee, United States View Trial Details
Active, Not Recruiting Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia NCT03573700 Conditions Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, +15 more Locations St. Jude Children's Research Hospital — Memphis, Tennessee, United States View Trial Details
